Pharmacist Benefit Co., Ltd. (“YSB”) announced on 25 April 2024 that under the 2023 Share Incentive Scheme, the Company had repurchased 100,000 shares on the market through trusts at a total cost of HK$797,806 at an average price of HK$7.98 per share. The move is intended to supplement the trust fund under the Share Incentive Scheme and held by the Trustee to meet the rewards awarded to eligible participants. The Board of Directors stated that the share buyback reflects the Company's confidence in the business outlook and considers the current share price to be below the Company's intrinsic value. In addition, share buybacks are seen as a strategy to attract talent and align employees' interests with those of the company. As a digitalized integrated service platform for the overseas medical industry in China, pharmacists plan to promote the health development of the industry with the development of the Internet medical industry through its network and technological innovations.

Pharmacist Benefit Co., Ltd. (“YSB”) announced on 25 April 2024 that under the 2023 Share Incentive Scheme, the Company had repurchased 100,000 shares on the market through trusts at a total cost of HK$797,806 at an average price of HK$7.98 per share. The move is intended to supplement the trust fund under the Share Incentive Scheme and held by the Trustee to meet the rewards awarded to eligible participants. The Board of Directors stated that the share buyback reflects the Company's confidence in the business outlook and considers the current share price to be below the Company's intrinsic value. In addition, share buybacks are seen as a strategy to attract talent and align employees' interests with those of the company. As a digitalized integrated service platform for the overseas medical industry in China, pharmacists plan to promote the health development of the industry with the development of the Internet medical industry through its network and technological innovations.